CDRD Invests in Sitka Biopharma to Advance Bladder Cancer Treatment to Clinical Trial

February 11, 2019 by Sitkastaff

Vancouver, Canada – CDRD, Canada’s national life sciences venture, is pleased to announce an increased commitment to Sitka Biopharma with

Sitka Biopharma Announces New Investment from Global Health Sciences Fund

October 25, 2018 by Sitkastaff

Vancouver, Canada: Sitka Biopharma is pleased to announce that Quark Venture Inc. and GF Securities, through their Global Health Sciences

August 29, 2017 by sitkaadmin

Sitka Biopharma Inc. is pleased to announce that Dr. Kristine Swiderek and Dr. Jack Geltosky have joined its Board of

August 7, 2017 by Sitkastaff

Quark Venture’s early investment in Sitka Biopharma helps the Vancouver-based company advance to clinical trials. We are pleased to announce

June 26, 2017 by Sitkastaff

June 26, 2017 – Vancouver, BC and London, UK: An experimental treatment for bladder cancer will move into an early

March 6, 2017 by Sitkastaff

On March 3, 2017 Rocket Builders announced its 15th annual “Ready to Rocket” lists. These lists profile British Columbia technology

April 13, 2016 by Sitkastaff

Vancouver, Canada – April 13, 2016: Sitka Biopharma is pleased to announce that Quark Venture has made a significant seed

June 25, 2015 by Sitkastaff

Learn more about Sitka Biopharma’s unique approach to bladder cancer in International Innovation! Drs Helen Burt, Michael Parr, Richard Liggins and

December 3, 2013 by sitkaadmin

Vancouver, Canada – December 3, 2013: CDRD Ventures Inc. (CVI), the commercialization vehicle of The Centre for Drug Research and